CTAS
Cintas
Data as of 2026-09-05
Company attributes
Price
Interactive 5-year price history chart for CTAS. Latest close $201.05.
Pillar breakdown
0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)
- QualityProfit margins & asset efficiency94ExceptionalIndustrials median (n=263) 50
- ValuePrice vs fundamentals11PoorIndustrials median (n=263) 50
- GrowthRevenue & earnings trajectory48AverageIndustrials median (n=263) 51
- MomentumRecent price strength51AverageIndustrials median (n=263) 48
- HealthBalance sheet & solvency70ExceptionalIndustrials median (n=263) 57
- ProfitabilityROE, ROA, ROIC91ExceptionalIndustrials median (n=263) 50
- TechnicalTrend & volatility signals67StrongIndustrials median (n=263) 41
- RiskVolatility & drawdown profile64StrongIndustrials median (n=263) 48
Pillars not shown: Sentiment, ML (Phase 5+).
Fair price check
6 different valuation methods each estimate what CTAS should be worth, then we compare to today's price.
- P/E multiplesOvervaluedthinks it's expensive — estimates $120.46, about 40% below today
- EV/EBITDAOvervaluedthinks it's expensive — estimates $104.70, about 48% below today
- DCF (2-stage)Overvaluedthinks it's expensive — estimates $50.64, about 75% below today
- P/B multiplesOutlierestimate looks unreliable — estimates $36.24 — likely unreliable
- Graham (defensive)Outlierestimate looks unreliable — estimates $20.19 — likely unreliable
- Residual IncomeOutlierestimate looks unreliable — estimates $7.06 — likely unreliable
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
- Median fair
- $43.44
- Margin of safety(vs fair value)
- < −99%
- Max (ex-outliers)
- $120.46
- Tangible BVPS
- $2.22
- Goodwill-heavy balance sheet
- Extreme Graham estimate
- Extreme P/B estimate
- Extreme Residual-Income estimate
- Majority of methods extreme
Median of all applicable methods (current price $201.05). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.
Supporting dataRaw fundamentals & data-quality provenance behind the scores above
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $80.45B |
| Revenue (TTM) | $11.26B |
| Net income (TTM) | $2.00B |
| Operating cash flow (TTM) | $2.28B |
| CapEx (TTM) | $395.11M |
| Free cash flow (TTM)CFO − CapEx | $1.88B |
| Total assets | $10.53B |
| Total liabilities | N/A |
| Stockholders' equity | $5.14B |
| Cash & equivalents | $289.02M |
| Shares outstanding | 400.17M |
| EPS (basic) | $5.00 |
| EPS (diluted) | $5.00 |
| P/E ratio (TTM) | 40.23 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-07-29
- Latest period end
- 2026-06-30
- Filing lag
- 38 days
- Missing metrics
- 2(total_liabilities, research_and_development)
Composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars are reserved for a later phase; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.